Frontiers | Molecular Mechanisms and Therapeutic Targets of Cancer Metastasis and Therapy Resistance

Molecular Mechanisms and Therapeutic Targets of Cancer Metastasis and Therapy Resistance

3,477
Total downloads
10k
Total views and downloads

Articles

CASE REPORT

Published on 19 Apr 2024

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

Siyuan Huang
Linlin Li
Ningning Yan
Huixian Zhang
Qianqian Guo
Sanxing Guo
Di Geng
Xincheng Liu
Xingya Li

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment

doi 10.3389/fonc.2024.1331387

778 views
2 citations

REVIEW

Published on 22 Dec 2023

Desmoglein-2 as a cancer modulator: friend or foe?

Kay K. Myo Min
Charlie B. Ffrench
Barbara J. McClure
Michael Ortiz
Emma L. Dorward
Michael S. Samuel
Lisa M. Ebert
Mỹ G. Mahoney
Claudine S. Bonder

Desmoglein-2 as a cancer modulator: friend or foe?

doi 10.3389/fonc.2023.1327478

2,529 views

REVIEW

Published on 07 Nov 2023

Cuproptosis: emerging biomarkers and potential therapeutics in cancers

Min Wang
Lianwen Zheng
Shuai Ma
Ruixin Lin
Jiahui Li
Shuli Yang

Cuproptosis: emerging biomarkers and potential therapeutics in cancers

doi 10.3389/fonc.2023.1288504

3,328 views
10 citations

ORIGINAL RESEARCH

Published on 30 Oct 2023

Fanconi anemia pathway regulation by FANCI in prostate cancer

Heidi Kaljunen
Sinja Taavitsainen
Roosa Kaarijärvi
Eerika Takala
Ville Paakinaho
Matti Nykter
G. Steven Bova
Kirsi Ketola

Fanconi anemia pathway regulation by FANCI in prostate cancer

doi 10.3389/fonc.2023.1260826

1,912 views
3 citations

Share on

Frontiers in Oncology

Frontiers in Oncology

Cancer Molecular Targets and Therapeutics
Thoracic Oncology

Impact

10kTopic views
6,449Article views
3,477Article downloads